Brown Brothers Harriman & Co. »

Maxcyte shares owned by Brown Brothers Harriman & Co.

Quarter-by-quarter ownership of Maxcyte (MXCT) shares owned by Brown Brothers Harriman & Co. from 13F filings

Historical chart of Brown Brothers Harriman & Co. investment in Maxcyte

Tip: Access up to 7 years of quarterly data

All positions including Maxcyte held by Brown Brothers Harriman & Co. consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Maxcyte by Brown Brothers Harriman & Co.

Quarter filed Position value Share count Share price at filing
2023-12-31 $29k 6.3k 4.70
2023-09-30 $20k 6.3k 3.12
2023-06-30 $29k 6.3k 4.59
2023-03-31 $31k 6.3k 4.95
2022-12-31 $34k 6.3k 5.46
2022-09-30 $41k 6.3k 6.55

More positions owned by Brown Brothers Harriman & Co.

Berkshire Hathaway Inc-cl B Common Stock (BRK.B)
Microsoft Corp Common Stock (MSFT)
Alphabet Inc-cl C Common Stock (GOOG)
Linde Common Stock (LIN)
Mastercard Inc - A Common Stock (MA)
Zoetis Common Stock (ZTS)
Waste Management Common Stock (WM)
Oracle Corp Common Stock (ORCL)
Kla Corp Common Stock (KLAC)
Progressive Corp Common Stock (PGR)
Arthur J Gallagher & Co Common Stock (AJG)
Alcon Common Stock (ALC)
Amazon.com Common Stock (AMZN)
Booking Holdings Common Stock (BKNG)
Thermo Fisher Scientific Common Stock (TMO)

View all positions for Brown Brothers Harriman & Co.

Top funds holding Maxcyte

Cadian Capital Management
Vanguard Group
Vitruvian Partners
Millennium Management
Portolan Capital Management
Massachusetts Financial Services
Blue Water Life Science Advisors
River & Mercantile Asset Management
Arrowpoint Asset Management
Dimensional Fund Advisors
Willis Investment Counsel
Fred Alger Management
Roubaix Capital
Lazard Asset Management
Bank of New York Mellon

View all funds holding Maxcyte